You’ve Already Paid $6 Billion For Weight-Loss Drugs You Can’t Afford
U.S. taxpayers spent billions developing Ozempic-type diabetes and weight-loss drugs — now those drugs’ markups could bankrupt the U.S. health care system.
Pharma
The Billion-Dollar Taxpayer Math Behind The Ozempic Boom
How Americans spent $6.2 billion to develop overpriced diabetes and weight-loss drugs.
YOU LOVE TO SEE IT: Whole Foods Workers Take On Bezos
Whole Foods workers are made whole, corporate criminals face the music, private equity loses its painkillers, and an empire of pain gets a taste of its own medicine.
The Deadly Secrets Behind “Breakthrough” Alzheimer’s Drugs
Regulators approved controversial therapies amid excess deaths, questionable efficacy, and conflicts of interest.
Drug Commercials Aren’t Just Annoying — They’re Costing You Money
While proponents claim direct-to-consumer drug ads educate consumers, critics say that mass-market misinformation is costing patients and taxpayers alike.
Who’s Killing Your Independent Pharmacy?
As corporate pharmacy middlemen slash reimbursement fees to independent drugstores, local Illinois pharmacists push for legislative change.
YOU LOVE TO SEE IT: Happy Math For Public Schools
Plus, free tax filing pays off, electric vehicles work double time, and pharmaceutical giants face scrutiny for outrageous pricing.
Universities Are Making Billions Gatekeeping Your Meds
The University of California has raked in a previously undisclosed $1.6 billion from Xtandi sales, and now doesn’t want the government lowering exorbitant drug costs.